Latest News & Features
Americas
A US House of Representatives committee has begun a probe into Allergan’s patent deal with a Native American tribe. 4 October 2017
Americas
French non-profit foundation Institut Pasteur has sued Abbott Laboratories, a former licensee of a patent covering in vitro diagnostic methods directed to HIV.
4 October 2017
Africa
The World Intellectual Property Organization (WIPO) has partnered with trade group the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) to boost access to patent information. 3 October 2017
Americas
The US Food and Drug Administration has issued new guidance as part of its bid to target the barriers to generic drug competition. 3 October 2017
Americas
The US Court of Appeals for the Federal Circuit has backed Boston Scientific in its dispute with inventor David Jang, issuing a precedential ruling. 2 October 2017
article
Canada has a robust and reliable framework for resolving IP disputes, and it shouldn’t be ignored by litigants, say Ron Dimock, Sangeetha Punniyamoorthy and Nikolas Purcell of DLA Piper. 2 October 2017
Americas
Hospira has appealed against a verdict which saw Amgen secure $70 million in damages over a biosimilar dispute between the two companies. 2 October 2017
Big Pharma
The European Medicines Agency (EMA) has claimed that relocation to eight unidentified cities would result in “permanent damage to the system”. 29 September 2017
Americas
AbbVie has settled its patent dispute over Amgen’s proposed biosimilar for Humira (adalimumab), a drug used to treat multiple types of arthritis as well as psoriasis. 29 September 2017
Americas
Unlike in Europe, the lack of a plausibility threshold in the US means that those applying for patents there are more likely to be granted a broader claim. 28 September 2017